Granzymes regulate proinflammatory cytokine responses

Journal of Immunology

Volumn 194, Issue 2, 2015, Pages 491-497

  Wensink, Annette C ^a   Hack, C Erik ^a   Bovenschen, Niels ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANZYME; GRANZYME A; GRANZYME B; GRANZYME H; GRANZYME K; GRANZYME M; GRANZYME N; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID;

ALLERGIC PNEUMONITIS; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; INFLAMMATION; MALARIA FALCIPARUM; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; VIRUS INFECTION; ANIMAL; AUTOIMMUNE DISEASE; IMMUNOLOGY; INFECTION; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; GRANZYMES; HUMANS; INFECTION; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 84920432633     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401214     Document Type: Review

References (93)

1. Anthony, D. A., D. M. Andrews, S. V. Watt, J. A. Trapani, and M. J. Smyth. 2010. Functional dissection of the granzyme family: cell death and inflammation. Immunol. Rev. 235: 73-92.
2. Bovenschen, N., and J. A. Kummer. 2010. Orphan granzymes find a home. Immunol. Rev. 235: 117-127.
3. de Poot, S. A., and N. Bovenschen. 2014. Granzyme M: behind enemy lines. Cell Death Differ. 21: 359-368.
4. Chowdhury, D., and J. Lieberman. 2008. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26: 389-420.
5. Susanto, O., J. A. Trapani, and D. Brasacchio. 2012. Controversies in granzyme biology. Tissue Antigens 80: 477-487.
6. Joeckel, L. T., and P. I. Bird. 2014. Are all granzymes cytotoxic in vivo? Biol. Chem. 395: 181-202.
7. Sattar, R., S. A. Ali, and A. Abbasi. 2003. Bioinformatics of granzymes: Sequence comparison and structural studies on granzyme family by homology modeling. Biochem. Biophys. Res. Commun. 308: 726-735.
8. Bovenschen, N., R. Quadir, A. L. van den Berg, A. B. Brenkman, I. Vandenberghe, B. Devreese, J. Joore, and J. A. Kummer. 2009. Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A. J. Biol. Chem. 284: 3504-3512.
9. Kaiserman, D., S. E. Stewart, K. Plasman, K. Gevaert, P. Van Damme, and P. I. Bird. 2014. Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A. J. Biol. Chem. 289: 9408-9417.
10. Joeckel, L. T., R. Wallich, P. Martin, D. Sanchez-Martinez, F. C. Weber, S. F. Martin, C. Borner, J. Pardo, C. Froelich, and M. M. Simon. 2011. Mouse granzyme K has pro-inflammatory potential. Cell Death Differ. 18: 1112-1119.
11. Metkar, S. S., C. Menaa, J. Pardo, B. Wang, R. Wallich, M. Freudenberg, S. Kim, S. M. Raja, L. Shi, M. M. Simon, and C. J. Froelich. 2008. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29: 720-733.
12. Bovenschen, N., S. N. Spijkers, A. C. Wensink, I. M. Schellens, R. van Domselaar, and D. van Baarle. 2014. Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation. Clin. Immunol. 150: 1-11.
13. Hollestelle, M. J., K. W. Lai, M. van Deuren, P. J. Lenting, P. G. de Groot, T. Sprong, and N. Bovenschen. 2011. Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacity. PLoS ONE 6: e24216.
14. Bratke, K., A. Klug, P. Julius, M. Kuepper, M. Lommatzsch, G. Sparmann, W. Luttmann, and J. C. Virchow. 2008. Granzyme K: A novel mediator in acute airway inflammation. Thorax 63: 1006-1011.
15. Rucevic, M., L. D. Fast, G. D. Jay, F. M. Trespalcios, A. Sucov, E. Siryaporn, and Y. P. Lim. 2007. Altered levels and molecular forms of granzyme K in plasma from septic patients. Shock 27: 488-493.
16. Bade, B., J. Lohrmann, A. ten Brinke, A. M. Wolbink, G. J. Wolbink, I. J. ten Berge, J. C. Virchow Jr., W. Luttmann, and C. E. Hack. 2005. Detection of soluble human granzyme K in vitro and in vivo. Eur. J. Immunol. 35: 2940-2948.
17. Zeerleder, S., C. E. Hack, C. Caliezi, G. van Mierlo, A. Eerenberg-Belmer, A. Wolbink, and W. A. Wuillenmin. 2005. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction. Clin. Immunol. 116: 158-165.
18. Hermsen, C. C., Y. Konijnenberg, L. Mulder, C. Loé, M. van Deuren, J. W. van der Meer, G. J. van Mierlo, W. M. Eling, C. E. Hack, and R. W. Sauerwein. 2003. Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin. Exp. Immunol. 132: 467-472.
19. Lauw, F. N., A. J. Simpson, C. E. Hack, J. M. Prins, A. M. Wolbink, S. J. van Deventer, W. Chaowagul, N. J. White, and T. van Der Poll. 2000. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to Gram-negative bacteria. J. Infect. Dis. 182: 206-213.
20. Tremblay, G. M., A. M. Wolbink, Y. Cormier, and C. E. Hack. 2000. Granzyme activity in the inflamed lung is not controlled by endogenous serine proteinase inhibitors. J. Immunol. 165: 3966-3969.
21. Tak, P. P., L. Spaeny-Dekking, M. C. Kraan, F. C. Breedveld, C. J. Froelich, and C. E. Hack. 1999. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 116: 366-370.
22. Spaeny-Dekking, E. H., W. L. Hanna, A. M. Wolbink, P. C. Wever, J. A. Kummer, A. J. Swaak, J. M. Middeldorp, H. G. Huisman, C. J. Froelich, and C. E. Hack. 1998. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 160: 3610-3616.
23. Sayers, T. J., T. A. Wiltrout, R. Sowder, W. L. Munger, M. J. Smyth, and L. E. Henderson. 1992. Purification of a factor from the granules of a rat natural killer cell line (RNK) that reduces tumor cell growth and changes tumor morphology. Molecular identity with a granule serine protease (RNKP-1). J. Immunol. 148: 292-300.
24. van Domselaar, R., and N. Bovenschen. 2011. Cell death-independent functions of granzymes: hit viruses where it hurts. Rev. Med. Virol. 21: 301-314.
25. Andrade, F. 2010. Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state. Immunol. Rev. 235: 128-146.
26. Hiebert, P. R., and D. J. Granville. 2012. Granzyme B in injury, inflammation, and repair. Trends Mol. Med. 18: 732-741.
27. Hendel, A., P. R. Hiebert, W. A. Boivin, S. J. Williams, and D. J. Granville. 2010. Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ. 17: 596-606.
28. Sorokin, L. 2010. The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 10: 712-723.
29. Boivin, W. A., D. M. Cooper, P. R. Hiebert, and D. J. Granville. 2009. Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab. Invest. 89: 1195-1220.
30. Buzza, M. S., and P. I. Bird. 2006. Extracellular granzymes: current perspectives. Biol. Chem. 387: 827-837.
31. Boivin, W. A., M. Shackleford, A. Vanden Hoek, H. Zhao, T. L. Hackett, D. A. Knight, and D. J. Granville. 2012. Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-b1. PLoS ONE 7: e33163.
32. Buzza, M. S., L. Zamurs, J. Sun, C. H. Bird, A. I. Smith, J. A. Trapani, C. J. Froelich, E. C. Nice, and P. I. Bird. 2005. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J. Biol. Chem. 280: 23549-23558.
33. Choy, J. C., V. H. Hung, A. L. Hunter, P. K. Cheung, B. Motyka, I. S. Goping, T. Sawchuk, R. C. Bleackley, T. J. Podor, B. M. McManus, and D. J. Granville. 2004. Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: Involvement of extracellular matrix degradation. Arterioscler. Thromb. Vasc. Biol. 24: 2245-2250.
34. Ronday, H. K., W. H. van der Laan, P. P. Tak, J. A. de Roos, R. A. Bank, J. M. TeKoppele, C. J. Froelich, C. E. Hack, P. C. Hogendoorn, F. C. Breedveld, and J. H. Verheijen. 2001. Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology (Oxford) 40: 55-61.
35. Froelich, C. J., X. Zhang, J. Turbov, D. Hudig, U. Winkler, and W. L. Hanna. 1993. Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J. Immunol. 151: 7161-7171.
36. Hiebert, P. R., D. Wu, and D. J. Granville. 2013. Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice. Cell Death Differ. 20: 1404-1414.
37. Hiebert, P. R., W. A. Boivin, T. Abraham, S. Pazooki, H. Zhao, and D. J. Granville. 2011. Granzyme B contributes to extracellular matrix remodeling and skin aging in apolipoprotein E knockout mice. Exp. Gerontol. 46: 489-499.
38. Ang, L. S., W. A. Boivin, S. J. Williams, H. Zhao, T. Abraham, K. Carmine- Simmen, B. M. McManus, R. C. Bleackley, and D. J. Granville. 2011. Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cell Death Dis. 2: e209.
39. Chamberlain, C. M., L. S. Ang, W. A. Boivin, D. M. Cooper, S. J. Williams, H. Zhao, A. Hendel, M. Folkesson, J. Swedenborg, M. F. Allard, et al. 2010. Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm. Am. J. Pathol. 176: 1038-1049.
40. Hirayasu, H., Y. Yoshikawa, S. Tsuzuki, and T. Fushiki. 2008. A lymphocyte serine protease granzyme A causes detachment of a small-intestinal epithelial cell line (IEC-6). Biosci. Biotechnol. Biochem. 72: 2294-2302.
41. Vettel, U., G. Brunner, R. Bar-Shavit, I. Vlodavsky, and M. D. Kramer. 1993. Charge-dependent binding of granzyme A (MTSP-1) to basement membranes. Eur. J. Immunol. 23: 279-282.
42. Simon, M. M., M. D. Kramer, M. Prester, and S. Gay. 1991. Mouse T-cell associated serine proteinase 1 degrades collagen type IV: A structural basis for the migration of lymphocytes through vascular basement membranes. Immunology 73: 117-119.
43. Simon, M. M., M. Prester, G. Nerz, M. D. Kramer, and U. Fruth. 1988. Release of biologically active fragments from human plasma-fibronectin by murine T cellspecific proteinase 1 (TSP-1). Biol. Chem. Hoppe Seyler 369(Suppl): 107-112.
44. Anthony, D. A., D. M. Andrews, M. Chow, S. V. Watt, C. House, S. Akira, P. I. Bird, J. A. Trapani, and M. J. Smyth. 2010. A role for granzyme M in TLR4- driven inflammation and endotoxicosis. J. Immunol. 185: 1794-1803.
45. Sower, L. E., G. R. Klimpel, W. Hanna, and C. J. Froelich. 1996. Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell. Immunol. 171: 159-163.
46. Sower, L. E., C. J. Froelich, N. Allegretto, P. M. Rose, W. D. Hanna, and G. R. Klimpel. 1996. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J. Immunol. 156: 2585-2590.
47. Irmler, M., S. Hertig, H. R. MacDonald, R. Sadoul, J. D. Becherer, A. Proudfoot, R. Solari, and J. Tschopp. 1995. Granzyme A is an interleukin 1 beta-converting enzyme. J. Exp. Med. 181: 1917-1922.
48. Wensink, A. C., V. Kemp, J. Fermie, M. I. García Laorden, T. van der Poll, C. E. Hack, and N. Bovenschen. 2014. Granzyme K synergistically potentiates LPSinduced cytokine responses in human monocytes. Proc. Natl. Acad. Sci. USA 111: 5974-5979.
49. Spencer, C. T., G. Abate, I. G. Sakala, M. Xia, S. M. Truscott, C. S. Eickhoff, R. Linn, A. Blazevic, S. S. Metkar, G. Peng, et al. 2013. Granzyme A produced by g9d2 T cells induces human macrophages to inhibit growth of an intracellular pathogen. PLoS Pathog. 9: e1003119.
50. Afonina, I. S., G. A. Tynan, S. E. Logue, S. P. Cullen, M. Bots, A. U. Luthi, E. P. Reeves, N. G. McElvaney, J. P. Medema, E. C. Lavelle, and S. J. Martin. 2011. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1a. Mol. Cell 44: 265-278.
51. + T cell granzyme B activates keratinocyte endogenous IL-18. Arch. Dermatol. Res. 306: 125-130.
52. Omoto, Y., K. Yamanaka, K. Tokime, S. Kitano, M. Kakeda, T. Akeda, I. Kurokawa, E. C. Gabazza, H. Tsutsui, N. Katayama, et al. 2010. Granzyme B is a novel interleukin-18 converting enzyme. J. Dermatol. Sci. 59: 129-135.
53. Cooper, D. M., D. V. Pechkovsky, T. L. Hackett, D. A. Knight, and D. J. Granville. 2011. Granzyme K activates protease-activated receptor-1. PLoS ONE 6: e21484.
54. Baschuk, N., N. Wang, S. V. Watt, H. Halse, C. House, P. I. Bird, R. Strugnell, J. A. Trapani, M. J. Smyth, and D. M. Andrews. 2014. NK cell intrinsic regulation of MIP-1a by granzyme M. Cell Death Dis. 5: e1115.
55. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G. M. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25: 1071-1079.
56. Manna, P. P., S. K. Hira, A. A. Das, S. Bandyopadhyay, and K. K. Gupta. 2013. IL- 15 activated human peripheral blood dendritic cell kill allogeneic and xenogeneic endothelial cells via apoptosis. Cytokine 61: 118-126.
57. Bratke, K., J. Nielsen, F. Manig, C. Klein, M. Kuepper, S. Geyer, P. Julius, M. Lommatzsch, and J. C. Virchow. 2010. Functional expression of granzyme B in human plasmacytoid dendritic cells: A role in allergic inflammation. Clin. Exp. Allergy 40: 1015-1024.
58. Jahrsdörfer, B., A. Vollmer, S. E. Blackwell, J. Maier, K. Sontheimer, T. Beyer, B. Mandel, O. Lunov, K. Tron, G. U. Nienhaus, et al. 2010. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 115: 1156-1165.
59. Stary, G., C. Bangert, M. Tauber, R. Strohal, T. Kopp, and G. Stingl. 2007. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 204: 1441-1451.
60. Karrich, J. J., L. C. Jachimowski, M. Nagasawa, A. Kamp, M. Balzarolo, M. C. Wolkers, C. H. Uittenbogaart, S. Marieke van Ham, and B. Blom. 2013. IL- 21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation. Blood 121: 3103-3111.
61. Tel, J., S. Anguille, C. E. Waterborg, E. L. Smits, C. G. Figdor, and I. J. de Vries. 2014. Tumoricidal activity of human dendritic cells. Trends Immunol. 35: 38-46.
62. Zangi, L., Y. Z. Klionsky, L. Yarimi, E. Bachar-Lustig, Y. Eidelstein, E. Shezen, D. Hagin, Y. Ito, T. Takai, S. Reich-Zeliger, et al. 2012. Deletion of cognate CD8 T cells by immature dendritic cells: A novel role for perforin, granzyme A, TREM-1, and TLR7. Blood 120: 1647-1657.
63. Lindner, S., K. Dahlke, K. Sontheimer, M. Hagn, C. Kaltenmeier, T. F. Barth, T. Beyer, F. Reister, D. Fabricius, R. Lotfi, et al. 2013. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 73: 2468-2479.
64. Hagn, M., K. Sontheimer, K. Dahlke, S. Brueggemann, C. Kaltenmeier, T. Beyer, S. Hofmann, O. Lunov, T. F. Barth, D. Fabricius, et al. 2012. Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol. Cell Biol. 90: 457-467.
65. Hagn, M., E. Schwesinger, V. Ebel, K. Sontheimer, J. Maier, T. Beyer, T. Syrovets, Y. Laumonnier, D. Fabricius, T. Simmet, and B. Jahrsdörfer. 2009. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J. Immunol. 183: 1838-1845.
66. Hagn, M., and B. Jahrsdörfer. 2012. Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway. OncoImmunology 1: 1368-1375.
67. Hagn, M., G. T. Belz, A. Kallies, V. R. Sutton, K. Y. Thia, D. M. Tarlinton, E. D. Hawkins, and J. A. Trapani. 2012. Activated mouse B cells lack expression of granzyme B. J. Immunol. 188: 3886-3892.
68. Kim, W. J., H. Kim, K. Suk, and W. H. Lee. 2007. Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis. Immunol. Lett. 111: 57-65.
69. Tschopp, C. M., N. Spiegl, S. Didichenko, W. Lutmann, P. Julius, J. C. Virchow, C. E. Hack, and C. A. Dahinden. 2006. Granzyme B, a novel mediator of allergic inflammation: Its induction and release in blood basophils and human asthma. Blood 108: 2290-2299.
70. Strik, M. C., P. J. de Koning, M. J. Kleijmeer, B. A. Bladergroen, A. M. Wolbink, J. M. Griffith, D. Wouters, Y. Fukuoka, L. B. Schwartz, C. E. Hack, et al. 2007. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol. Immunol. 44: 3462-3472.
71. Eckert, J. K., Y. J. Kim, J. I. Kim, K. Gürtler, D. Y. Oh, S. Sur, L. Lundvall, L. Hamann, A. van der Ploeg, P. Pickkers, et al. 2013. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity 39: 647-660.
72. Lamping, N., A. Hoess, B. Yu, T. C. Park, C. J. Kirschning, D. Pfeil, D. Reuter, S. D. Wright, F. Herrmann, and R. R. Schumann. 1996. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)- binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157: 4648-4656.
73. Heinzelmann, M., H. C. Polk Jr., and F. N. Miller. 1998. Modulation of lipopolysaccharide-induced monocyte activation by heparin-binding protein and fucoidan. Infect. Immun. 66: 5842-5847.
74. Rasmussen, P. B., S. Bjørn, S. Hastrup, P. F. Nielsen, K. Norris, L. Thim, F. C. Wiberg, and H. Flodgaard. 1996. Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPSinduced cytokine release from monocytes. FEBS Lett. 390: 109-112.
75. Hreggvidsdottir, H. S., T. Ostberg, H. Wähämaa, H. Schierbeck, A. C. Aveberger, L. Klevenvall, K. Palmblad, L. Ottosson, U. Andersson, and H. E. Harris. 2009. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86: 655-662.
76. Youn, J. H., Y. J. Oh, E. S. Kim, J. E. Choi, and J. S. Shin. 2008. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-a production in human monocytes. J. Immunol. 180: 5067-5074.
77. Bosshart, H., and M. Heinzelmann. 2002. Arginine-rich cationic polypeptides amplify lipopolysaccharide-induced monocyte activation. Infect. Immun. 70: 6904- 6910.
78. Berbée, J. F., C. P. Coomans, M. Westerterp, J. A. Romijn, L. M. Havekes, and P. C. Rensen. 2010. Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- And C-terminal helix. J. Lipid Res. 51: 1943-1952.
79. Berbée, J. F., C. C. van der Hoogt, R. Kleemann, E. F. Schippers, R. L. Kitchens, J. T. van Dissel, I. A. Bakker-Woudenberg, L. M. Havekes, and P. C. Rensen. 2006. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J. 20: 2162-2164.
80. Heinzelmann, M., A. Platz, H. Flodgaard, H. C. Polk Jr., and F. N. Miller. 1999. Endocytosis of heparin-binding protein (CAP37) is essential for the enhancement of lipopolysaccharide-induced TNF-a production in human monocytes. J. Immunol. 162: 4240-4245.
81. Kaiserman, D., and P. I. Bird. 2010. Control of granzymes by serpins. Cell Death Differ. 17: 586-595.
82. Wells, M. J., W. P. Sheffield, and M. A. Blajchman. 1999. The clearance of thrombin-antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors. Thromb. Haemost. 81: 325-337.
83. Strickland, D. K., and M. Z. Kounnas. 1997. Mechanisms of cellular uptake of thrombin-antithrombin II complexes role of the low-density lipoprotein receptorrelated protein as a serpin-enzyme complex receptor. Trends Cardiovasc. Med. 7: 9- 16.
84. Lu, F., J. Lamontagne, A. Sun, M. Pinkerton, T. Block, and X. Lu. 2011. Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis. Immunology 134: 398-408.
85. Spaeny-Dekking, E. H., A. M. Kamp, C. J. Froelich, and C. E. Hack. 2000. Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitors. Blood 95: 1465-1472.
86. Sun, J., C. H. Bird, V. Sutton, L. McDonald, P. B. Coughlin, T. A. De Jong, J. A. Trapani, and P. I. Bird. 1996. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271: 27802-27809.
87. Rowshani, A. T., M. C. Strik, R. Molenaar, S. L. Yong, A. M. Wolbink, F. J. Bemelman, C. E. Hack, and I. J. Ten Berge. 2005. The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J. Infect. Dis. 192: 1908- 1911.
88. Kurschus, F. C., M. Kleinschmidt, E. Fellows, K. Dornmair, R. Rudolph, H. Lilie, and D. E. Jenne. 2004. Killing of target cells by redirected granzyme B in the absence of perforin. FEBS Lett. 562: 87-92.
89. Wang, L., Q. Li, L. Wu, S. Liu, Y. Zhang, X. Yang, P. Zhu, H. Zhang, K. Zhang, J. Lou, et al. 2013. Identification of SERPINB1 as a physiological inhibitor of human granzyme H. J. Immunol. 190: 1319-1330.
90. de Koning, P. J., J. A. Kummer, S. A. de Poot, R. Quadir, R. Broekhuizen, A. F. McGettrick, W. J. Higgins, B. Devreese, D. M. Worrall, and N. Bovenschen. 2011. Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death. PLoS ONE 6: e22645.
91. Mahrus, S., W. Kisiel, and C. S. Craik. 2004. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J. Biol. Chem. 279: 54275-54282.
92. Wilharm, E., M. A. Parry, R. Friebel, H. Tschesche, G. Matschiner, C. P. Sommerhoff, and D. E. Jenne. 1999. Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J. Biol. Chem. 274: 27331-27337.
93. Lim, Y. P., K. Bendelja, S. M. Opal, E. Siryaporn, D. C. Hixson, and J. E. Palardy. 2003. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J. Infect. Dis. 188: 919-926.